1. Home
  2. HAS vs EXAS Comparison

HAS vs EXAS Comparison

Compare HAS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$91.62

Market Cap

11.1B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$103.78

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
EXAS
Founded
1923
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1B
19.7B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
HAS
EXAS
Price
$91.62
$103.78
Analyst Decision
Strong Buy
Hold
Analyst Count
10
17
Target Price
$107.30
$86.62
AVG Volume (30 Days)
1.3M
1.8M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
3.06%
N/A
EPS Growth
N/A
80.32
EPS
N/A
N/A
Revenue
$5,365,900,000.00
$4,144,000.00
Revenue This Year
$5.33
$15.37
Revenue Next Year
$6.99
$12.41
P/E Ratio
N/A
N/A
Revenue Growth
13.06
N/A
52 Week Low
$49.00
$38.88
52 Week High
$106.98
$104.02

Technical Indicators

Market Signals
Indicator
HAS
EXAS
Relative Strength Index (RSI) 37.87 60.15
Support Level $74.08 $102.95
Resistance Level $106.98 $103.85
Average True Range (ATR) 2.41 0.32
MACD -0.92 -0.03
Stochastic Oscillator 6.14 77.57

Price Performance

Historical Comparison
HAS
EXAS

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: